The cost of GLP-1 drugs is a hot topic: the federal government announced last week that it has reached a deal with pharmaceutical companies to lower the cost of GLP-1 drugs, but it remains unclear exactly how this will affect patients
View AAPP's Disclaimer and Disclosure Declarations AAPP Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development
The reported weight loss represents uniform drug concentration, identical injection devices, and thousands of data points collected under identical conditions
Upon agonist binding, receptor internalization can be quantified in real-time through a luminescence assay, offering a sensitive and scalable method to study receptor trafficking and signaling dynamics
Biomed Pharmacother 102:855864
Tew KD, Monks A, Barone L, Rosser D, Akerman G, Montali JA, Wheatley JB and Schmidt Jr DE